[{"address1": "Ronda General Mitre, 151", "city": "Barcelona", "zip": "08022", "country": "Spain", "phone": "34 93 291 30 00", "website": "https://www.almirall.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Almirall, S.A., a biopharmaceutical company, engages in the purchase, manufacture, storage, and sale of skin-health medicines in Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising actinic keratosis, atopic dermatitis, alopecia areata, skin cancer, psoriasis, onychomycosis, vitiligo, hidradenitis suppurativa, oncodermatology, acne, orphan indications, and rare skin diseases, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, respiratory, and nervous system; dermatologicals; genito urinary system and sex hormones; immunostimulants; and systematic hormonal preparations. It has a multi-target alliance with Etherna to research and develop new mRNA-based therapies for severe skin diseases, including non-melanoma skin cancer. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.", "fullTimeEmployees": 1996, "companyOfficers": [{"maxAge": 1, "name": "Mr. Carlos  Gallardo Piqu\u00e9", "age": 51, "title": "CEO, President, Member of Management Board & Chairman of the Board", "yearBorn": 1972, "fiscalYear": 2015, "totalPay": 55886, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  McClellan", "age": 51, "title": "CFO & Member of Management Board", "yearBorn": 1972, "fiscalYear": 2015, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eloi  Crespo Cervera", "title": "Chief Industrial Operations Officer & Member of Management Board", "fiscalYear": 2015, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Esteve  Conesa Panicot", "title": "Chief People & Culture Officer and Member of Management Board", "fiscalYear": 2015, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Volker  Koscielny", "title": "Chief Medical Officer & Member of Management Board", "fiscalYear": 2015, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Karl  Ziegelbauer", "title": "Chief Scientific Officer & Member of Management Board", "fiscalYear": 2015, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paolo  Cionini", "title": "Chief Commercial Officer Europe & International and Member of Management Board", "fiscalYear": 2015, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Isabel Cristina Gomes", "title": "Company Vice Secretary,Chief Legal Officer, General Counsel & Member of Management Board", "fiscalYear": 2015, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mercedes  Diz Lopez", "title": "Chief Marketing Officer & Member of Management Board", "fiscalYear": 2015, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Pablo Divasson del Fraile", "title": "Senior Director of Investor Relations", "fiscalYear": 2015, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 3, "compensationRisk": 1, "shareHolderRightsRisk": 3, "overallRisk": 2, "governanceEpochDate": 1725148800, "compensationAsOfEpochDate": 1451520000, "maxAge": 86400, "priceHint": 2, "previousClose": 9.75, "open": 9.75, "dayLow": 9.75, "dayHigh": 9.75, "regularMarketPreviousClose": 9.75, "regularMarketOpen": 9.75, "regularMarketDayLow": 9.75, "regularMarketDayHigh": 9.75, "dividendRate": 0.2, "dividendYield": 0.0208, "exDividendDate": 1715904000, "payoutRatio": 1.1625, "beta": 0.388, "volume": 10, "regularMarketVolume": 10, "bid": 9.15, "ask": 10.1, "bidSize": 36200, "askSize": 41800, "marketCap": 2028102656, "fiftyTwoWeekLow": 9.0, "fiftyTwoWeekHigh": 10.18, "priceToSalesTrailing12Months": 2.17694, "fiftyDayAverage": 9.51, "twoHundredDayAverage": 9.4123, "trailingAnnualDividendRate": 0.19, "trailingAnnualDividendYield": 0.01948718, "currency": "USD", "enterpriseValue": 2110178560, "profitMargins": -0.03767, "floatShares": 76880759, "sharesOutstanding": 213260000, "heldPercentInsiders": 0.63975, "heldPercentInstitutions": 0.15777999, "bookValue": 6.964, "priceToBook": 1.3655945, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "earningsQuarterlyGrowth": 0.852, "netIncomeToCommon": -35099000, "trailingEps": -0.21, "enterpriseToRevenue": 2.265, "enterpriseToEbitda": 14.097, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "LBTSF", "underlyingSymbol": "LBTSF", "shortName": "Almirall SA", "longName": "Almirall, S.A.", "firstTradeDateEpochUtc": 1344000600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "ff8a7147-c78c-3f9e-9189-a1598fb76fae", "gmtOffSetMilliseconds": -14400000, "currentPrice": 9.51, "recommendationKey": "none", "totalCash": 330875008, "totalCashPerShare": 1.55, "ebitda": 149691008, "totalDebt": 410966016, "quickRatio": 1.858, "currentRatio": 2.53, "totalRevenue": 931630016, "debtToEquity": 27.645, "revenuePerShare": 4.729, "returnOnAssets": 0.011089999, "returnOnEquity": -0.023340002, "freeCashflow": -114229752, "operatingCashflow": 102691000, "earningsGrowth": 0.656, "revenueGrowth": 0.07, "grossMargins": 0.75365996, "ebitdaMargins": 0.16068001, "operatingMargins": 0.06957, "financialCurrency": "EUR", "trailingPegRatio": 0.2906, "__fetch_time": "2024-09-05"}]